BioCentury
ARTICLE | Deals

As German translational science begins to bloom, Evotec, BMS launch incubator in Rhine-Main-Neckar region

Evotec’s latest ‘BRIDGE’ incubator comes with $20M to accelerate academic research

April 17, 2021 12:29 AM UTC

An improving environment for translational science in Germany has prompted Evotec to launch its latest incubator in the country.

This week Evotec SE (Xetra:EVT) announced that it has partnered with Bristol Myers Squibb Co. (NYSE:BMY) to invest $20 million in the launch of beLAB2122, an academic-focused BRIDGE incubator in Germany’s Rhine-Main-Neckar region...